Increased expression of IGF-1R has been reported in many carcinomas including breast, prostate, pancreas and colon, and thus the blockade of IGF-1R activity can significantly induce growth inhibition and apoptosis in these cancer cells [24]–[26]. Here, IGF1R is linked to carcinoma.